Skip to main content
Livermore
Livermore
ZHEN

Captrust Financial Advisors

SEC CIK
0001512024
Latest filing
Aug 13, 2026

SRPT holding history

Sarepta Therapeutics, Inc. in every 13F filed by Captrust Financial Advisors, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SRPT overviewAll 13F holders of SRPTFull Q2 2026 holdings

Shares (Q2 2026)
21,745
Value
$390.8K
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of SRPT by Captrust Financial Advisors, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202621,745$390.8K<0.1%−18,396−45.8%ReducedHolders
Q1 202640,141$873.3K<0.1%−8,611−17.7%ReducedHolders
Q4 202548,752$1.05M<0.1%+35,517+268.4%AddedHolders
Q3 202513,235$255.0K<0.1%+13,235NewHolders
Q1 20250$00.0%−4,468−100.0%Sold outHolders
Q4 20244,468$543.3K<0.1%+597+15.4%AddedHolders
Q3 20243,871$483.4K<0.1%+511+15.2%AddedHolders
Q2 20243,360$530.9K<0.1%+938+38.7%AddedHolders
Q1 20242,422$313.6K<0.1%−2,448−50.3%ReducedHolders
Q4 20234,870$469.6K<0.1%−793−14.0%ReducedHolders
Q3 20235,663$686.5K<0.1%−235−4.0%ReducedHolders
Q2 20235,898$675.4K<0.1%−826−12.3%ReducedHolders
Q1 20236,724$926.8K<0.1%+783+13.2%AddedHolders
Q4 20225,941$769.8K<0.1%+2,153+56.8%AddedHolders
Q3 20223,788$419.0K<0.1%+317+9.1%AddedHolders
Q2 20223,471$260.0K<0.1%+44+1.3%AddedHolders
Q1 20223,427$268.0K<0.1%+77+2.3%AddedHolders
Q4 20213,350$302.0K<0.1%−2,627−44.0%ReducedHolders
Q3 20215,977$553.0K<0.1%−665−10.0%ReducedHolders
Q2 20216,642$516.0K<0.1%−101−1.5%ReducedHolders
Q1 20216,743$503.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.